Literature DB >> 26735399

The road less traveled: Start-ups invest in novel approaches against neurodegeneration.

Shraddha Chakradhar.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26735399     DOI： 10.1038/nm0116-11

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  2 in total

1.  Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.

Authors:  Roy N Alcalay; Tama Dinur; Timothy Quinn; Karina Sakanaka; Oren Levy; Cheryl Waters; Stanley Fahn; Tsvyatko Dorovski; Wendy K Chung; Michael Pauciulo; William Nichols; Huma Q Rana; Manisha Balwani; Louise Bier; Deborah Elstein; Ari Zimran
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

2.  The classical complement cascade mediates CNS synapse elimination.

Authors:  Beth Stevens; Nicola J Allen; Luis E Vazquez; Gareth R Howell; Karen S Christopherson; Navid Nouri; Kristina D Micheva; Adrienne K Mehalow; Andrew D Huberman; Benjamin Stafford; Alexander Sher; Alan M Litke; John D Lambris; Stephen J Smith; Simon W M John; Ben A Barres
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582
  2 in total
  2 in total

Review 1.  The renaissance of complement therapeutics.

Authors:  Daniel Ricklin; Dimitrios C Mastellos; Edimara S Reis; John D Lambris
Journal:  Nat Rev Nephrol       Date:  2017-12-04       Impact factor: 28.314

Review 2.  Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets.

Authors:  Sohaib Nizami; Hazel Hall-Roberts; Sharat Warrier; Sally A Cowley; Elena Di Daniel
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.